Refine by
Arthritis Rheumatoid Suppliers & Manufacturers
11 companies found
based inHuningue, FRANCE
FIRALIS is a biotechnology company located in the very heart of BioValley, on the true triple border of FR-DE-CH, only a few minutes walking distance to Basel, the pharmaceutical capital of Europe. Firalis creates novel values via biomarker ...
As part of the European IMI BT-Cure consortium followed by the H2020 RABIOPRED program launched in 2016, FIRALIS launches its proprietary assay for the identification of markers related to inflammatory-autoimmune ...
based inSurrey, BRITISH COLUMBIA (CANADA)
BioInteractive Technologies, endorsed by the Mayo Clinic & Techstars, is a Medical Device and Digital Health company developing intelligent wearables for physical therapy, using its patent-pending TENZR musculoskeletal sensing ...
Personalized physical therapy combined with the patented TENZR Trainer & Tracker ensures accurate rehabilitation of the hand, wrist, and ...
based inHong Kong, CHINA
Shengkang Fine Chemical (kinfon) is a leading company in the China chemicals market founded in 2010, is mainly focuses on innovation and development of the front-end businesses to differentiate its offerings. We undertakes the discovery, ...
based inRixensart, BELGIUM
CuraVac is a clinical-stage biotech company developing the medical and commercial potential of a revolutionary technique for the production of specific Therapeutic Vaccines for the treatment of autoimmune diseases. The company was founded by a ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Augurex develops biomarkers that transform patient clinical management for better disease outcomes by helping diagnose patients, whom when identified can be promptly treated. By biologically informing a clinical assessment, biomarkers optimize ...
Extracellular 14-3-3η protein is a potent ligand and activator of intracellular signalling pathways that lead to the up-regulation of inflammation and joint damage factors involved in RA pathogenesis. The 14-3-3η blood test is clinically ...
based inOxfordshire, UNITED KINGDOM
Owen Mumford is a global leader in medical device design and manufacture, leading innovation in this space and delivering medical device solutions that respond to customer and market needs. Now in our 70th year having collaborated with ...
based inDundee, UNITED KINGDOM
Our expertise encompasses the development of novel proprietary diagnostic tests in areas of clinical need and their incorporation onto the menus of the high throughput analysers of our partners, using a variety of assay technologies. Our proprietary ...
The measurement of anti-CCP antibodies has become the method of choice in the accurate diagnosis of Rheumatoid Arthritis. Anti-CCP2 positivity can predict future development of RA in both asymptomatic individuals ...
based inParis, FRANCE
Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections and cancer. As a clinical-stage company, Abivax leverages its immune enhancing and ...
ABX464 is an oral, first-in-class, small molecule that has demonstrated safety and profound anti-inflammatory activity in the completed Phase 2a and Phase 2b induction studies as well as in long-term maintenance studies in patients with ...
based inWaltham, MASSACHUSETTS (USA)
PrismRA is a molecular signature response classifier (MSRC) that uses gene expression features, clinical features and anti-cyclic citrullinated protein (anti-CCP) antibody to detect a signature of non-response to tumor necrosis factor-a inhibitors ...
based inMechelen, BELGIUM
Galapagos discovers, develops and commercializes small molecule medicines with novel modes of action. Our pipeline comprises discovery through to Phase 3 programs in inflammation, fibrosis, and other indications. Our first medicine is approved and ...
Filgotinib, a preferential JAK1 inhibitor, is marketed as Jyseleca in the European Union (incl. Norway), Great Britain, and Japan for the treatment of adults with moderately to severely active rheumatoid arthritis ...
based inValencia, CALIFORNIA (USA)
SetPoint Medical, headquartered in Valencia, Ca., is a privately-held clinical-stage bioelectronic medicine company dedicated to treating patients with chronic autoimmune diseases. The company is pioneering a new treatment paradigm, using electrical ...
The SetPoint Medical bioelectronic medicine platform delivers targeted electrical pulses to trigger the intrinsic inflammatory reflex. This pathway shows promise as an alternative, efficient treatment option for rheumatoid ...